Drug firm Eli Lilly and Company (India) said it has launched a product to treat early stage breast cancer after receiving approval from the Drug Controller General of India. The company has introduced Ramiven in strengths of 50 mg, 100 mg, 150 mg...
India’s pharma exports have increased 138 per cent in April-October 2022-23 compared to the same period of 2013-14 when the country became the pharmacy for the world...
Okyo Pharma Limited, an ophthalmology-focused bio-pharmaceutical company, announced that it filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for the development of OK-101 to treat dry eye disease...
Novel innovations are now actively hitting the market with an expectation to alter the course of drug manufacturing. In this article, we have listed the top trends in the RNA therapeutic industry:
Merck, known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (Imago) announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in...
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Procardia XL extended-release tablets, 30 mg, 60 mg and 90 mg, of Pfizer Inc...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced new data from a large aortic dissection artificial intelligence real-world study that supports the use of its artificial intelligence technology for...
Strides Pharma Science Ltd on Friday said its Singapore-based arm has received approval from the US health regulator for generic potassium chloride oral solution, used to treat or prevent low amounts of potassium in the blood. The approval granted...
Microvi, a transformative biology company based in the San Francisco Bay Area, announced that it has been awarded over $1.1 million in funding from the National Institute of Health (NIH) to scale-up its newly developed technology to eliminate ....
In this article, we have focused on recent innovations in the biopharmaceutical sector that has the potential to change pharmaceutical drug development.
, CDSCO.jpg)
